Literature DB >> 15998872

Overexpression of Rad23 confers resistance to methylmercury in saccharomyces cerevisiae via inhibition of the degradation of ubiquitinated proteins.

Gi-Wook Hwang1, Daisuke Sasaki, Akira Naganuma.   

Abstract

We report here that overexpression of Rad23, a protein related to the ubiquitin-proteasome system, renders yeast cells resistant to methylmercury. Rad23 has three domains: two ubiquitin-associated (UBA) domains that bind to the multiubiquitin chain of ubiquitinated proteins and a single ubiquitin-like (UbL) domain that binds to proteasomes. To examine the mechanism of acquisition of methylmercury resistance that is induced by overexpression of Rad23, we expressed variants of Rad23 in which one or the other of the two types of domain was defective in yeast cells. In cells that overexpressed full-length intact Rad23, we detected elevated levels of intracellular ubiquitinated proteins, and the cells were resistant to methylmercury. In contrast, cells that overexpressed Rad23 with a defective UBA domain were not resistant to methylmercury and contained control levels of ubiquitinated proteins. Yeast cells that overexpressed Rad23 with a defective UbL domain exhibited enhanced resistance to methylmercury and contained even higher levels of ubiquitinated proteins than cells that overexpressed intact full-length Rad23. Rad23 is known to have two mutually contradictory functions. It suppresses the degradation of ubiquitinated proteins by proteasomes via a mechanism mediated by the UBA domains, and it enhances the degradation of ubiquitinated proteins via a mechanism that is mediated by the UbL domain. Therefore, our findings suggest that Rad23 might induce resistance to methylmercury in yeast cells by suppressing the degradation of proteins that reduce the toxicity of methylmercury via a UBA domain-mediated mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15998872     DOI: 10.1124/mol.105.013516

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  8 in total

1.  Ubiquilin-1 is a molecular chaperone for the amyloid precursor protein.

Authors:  Emily S Stieren; Amina El Ayadi; Yao Xiao; Efraín Siller; Megan L Landsverk; Andres F Oberhauser; José M Barral; Darren Boehning
Journal:  J Biol Chem       Date:  2011-08-18       Impact factor: 5.157

2.  A system-based comparison of gene expression reveals alterations in oxidative stress, disruption of ubiquitin-proteasome system and altered cell cycle regulation after exposure to cadmium and methylmercury in mouse embryonic fibroblast.

Authors:  Xiaozhong Yu; Joshua F Robinson; Jaspreet S Sidhu; Sungwoo Hong; Elaine M Faustman
Journal:  Toxicol Sci       Date:  2010-01-08       Impact factor: 4.849

Review 3.  Ubiquitin-like and ubiquitin-associated domain proteins: significance in proteasomal degradation.

Authors:  Vivian Su; Alan F Lau
Journal:  Cell Mol Life Sci       Date:  2009-05-26       Impact factor: 9.261

4.  Comparative toxicogenomic responses of mercuric and methyl-mercury.

Authors:  Matthew K McElwee; Lindsey A Ho; Jeff W Chou; Marjolein V Smith; Jonathan H Freedman
Journal:  BMC Genomics       Date:  2013-10-11       Impact factor: 3.969

5.  Rad23 escapes degradation because it lacks a proteasome initiation region.

Authors:  Susan Fishbain; Sumit Prakash; Annie Herrig; Suzanne Elsasser; Andreas Matouschek
Journal:  Nat Commun       Date:  2011-02-08       Impact factor: 14.919

6.  Ubiquilin-1 and protein quality control in Alzheimer disease.

Authors:  Amina El Ayadi; Emily S Stieren; José M Barral; Darren Boehning
Journal:  Prion       Date:  2013-01-29       Impact factor: 3.931

7.  The protein transportation pathway from Golgi to vacuoles via endosomes plays a role in enhancement of methylmercury toxicity.

Authors:  Gi-Wook Hwang; Yasutaka Murai; Tsutomu Takahashi; Akira Naganuma
Journal:  Sci Rep       Date:  2014-07-30       Impact factor: 4.379

8.  Structural insights into pro-aggregation effects of C. elegans CRAM-1 and its human ortholog SERF2.

Authors:  Meenakshisundaram Balasubramaniam; Srinivas Ayyadevara; Robert J Shmookler Reis
Journal:  Sci Rep       Date:  2018-10-05       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.